Tocilizumab in multisystem inflammatory syndrome in children (MIS-C)-summarized experiences

J Eur Acad Dermatol Venereol. 2023 Apr;37(4):e443-e446. doi: 10.1111/jdv.18784. Epub 2022 Dec 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • COVID-19* / complications
  • Child
  • Humans
  • Systemic Inflammatory Response Syndrome* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related